ESWT vs HILT in Chronic Lateral Epicondylitis

Official title

Effectiveness of Shockwave Therapy Versus High-Power Laser Therapy in the Management of Chronic Lateral Epicondylitis: A Double-Blind Randomized Controlled Trial

Overview

This randomized controlled trial aims to compare the effectiveness of Extracorporeal Shock Wave Therapy (ESWT) and High-Intensity Laser Therapy (HILT) in patients with chronic lateral epicondylitis.

Detailed description

Participants will be randomly assigned into three groups receiving either conventional physiotherapy alone, ESWT plus conventional physiotherapy, or HILT plus conventional physiotherapy. Clinical assessments will be performed before and after treatment

Interventions

• Device Extracorporeal shock wave therapy
  The Group will receive ESWT plus conventional physiotherapy treatment program. Regarding ESWT protocol, the group will receive 1,000, 1,500, and 2,000 pulses during the first, second, and third through fifth treatments, respectively (pressure, 2.5 bar; frequency, 8 Hz; energy density, 0.4 mJ/mm2). The patients received 5 ESWT treatments once per week. The treatments were performed using a Rosetta ESWT (CR Technology, Korea). Ultrasound gel was applied between the apparatus head and skin. The pro
• Other Conventional Physical Therapy
  The conventional program will include TENS for twenty minutes in elbow region; the use of pulse ultrasound with duty cycle 80% on the lateral epicondyle for five minutes with an intensity of 0.8 W per every cm'; the use of ice for ten minutes; training for correcting the daily activities to minimize pressure on the elbow (preferentially, holding, lifting and pressing the objects will be asked to be carried out in supination); and, stretch and strain wrist muscle strengthening exercises (Fekri et
• Device High-power intinsty laser
  The Group will receive HILT plus conventional physiotherapy treatment program. High-power laser used in the present research paper was MLS Laser, Model M6 (ASA), that will be included in class four lasers device, with maximum 25-Watt power, average power of 3.3 Watts, wavelength of 808 nm in a continuous state. The target region diameter in this device will be 5 cm and the energy used for treating the patients will be 272.4 Jules, and the energy density will be 13.89 Jules per cm' with a 700-her

Primary outcome measures

• 1. Pain intensity measured using Visual Analogue Scale (VAS). [Time frame: at baseline 4 weeks and 8 weeks]
• 2. Grip strength measured using Hand Dynamometer. [Time frame: at baseline 4 weeks and 8 weeks]
• 3. Upper limb disability measured using QuickDASH Questionnaire. [Time frame: at baseline 4 weeks and 8 weeks]

Secondary outcome measures (4)

• 1. Pressure Pain Threshold using Algometer. [Time frame: at baseline 4 weeks and 8 weeks]
• 2. Pinch Strength Measurement. [Time frame: at baseline 4 weeks and 8 weeks]
• 3. Elbow Range of Motion (ROM). [Time frame: at baseline 4 weeks and 8 weeks]
• 4. Oxford Elbow Score (OES). [Time frame: at baseline 4 weeks and 8 weeks]

Eligibility criteria

Inclusion criteria

• • Age 40-50 years.

• Clinically diagnosed chronic lateral epicondylitis.
• Symptoms lasting more than 3 months.
• Positive clinical provocation tests.
• Localized tenderness over the lateral epicondyle.

Exclusion criteria

• • Previous elbow surgery.

• Corticosteroid injection within the last 6 months.
• Cervical radiculopathy.
• Peripheral nerve entrapment.
• Rheumatologic or systemic inflammatory disorders.
• Elbow fracture.
• Severe elbow instability

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation

Randomized

Model

Parallel assignment

Masking

Single blind

Primary purpose

Treatment

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07654790 · KFSIRB200-1048

Primary sources (government registries)

• ClinicalTrials.gov (US NIH)

View this study on ClinicalTrials.gov ↗